 Limited sampling models doxorubicin pharmacokinetics doxorubicin used antineoplastics studies date area concentration-time curve AUC toxicity response limited sampling model feasible method AUC pharmacodynamic studies Data previous studies doxorubicin pharmacokinetics patients sarcoma patients breast cancer unknown primary former training data set patients test datum set patients latter patients second test data set model stepwise multiple regression training data set AUC nanogram hour milliliter dose/ concentrations hours bolus dose model test data sets test data set mean predictive error MPE root mean square error RMSE second test data set MPE RMSE additional model simulated time point total AUC daily schedule AUC nanogram hour milliliter dose/ third dose AUC doxorubicin bolus administration plasma concentrations